ImmunoCellular Therapeutics (IMUC) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Share on StockTwits

ImmunoCellular Therapeutics (NASDAQ:IMUC) released its earnings data on Monday. The company reported ($0.04) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.06) by $0.02, American Banking News.com reports.

A number of research firms have recently commented on IMUC. Analysts at Roth Capital upgraded shares of ImmunoCellular Therapeutics from a “neutral” rating to a “buy” rating in a research note on Monday, June 2nd. They now have a $3.00 price target on the stock, up previously from $2.00. Analysts at Maxim Group cut their price target on shares of ImmunoCellular Therapeutics from $12.00 to $4.00 in a research note on Monday, June 2nd. They now have a “buy” rating on the stock. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $3.31.

ImmunoCellular Therapeutics (NASDAQ:IMUC) opened at 0.9159 on Monday. ImmunoCellular Therapeutics has a 52-week low of $0.65 and a 52-week high of $4.00. The stock’s 50-day moving average is $1.03 and its 200-day moving average is $1.19. The company’s market cap is $53.1 million.

ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors.

Receive News & Ratings for ImmunoCellular Therapeutics Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoCellular Therapeutics Ltd and related companies with Analyst Ratings Network's FREE daily email newsletter.

Latest News

Michigan Pondering Ban on Tesla
Michigan Pondering Ban on Tesla
Train Drivers in Germany Call Two-Day Strike
Train Drivers in Germany Call Two-Day Strike
Deadline Passes, No Word on Hostages Held in Philippines
Deadline Passes, No Word on Hostages Held in Philippines
Netflix Monthly Price Hike Weighs Down Growth
Netflix Monthly Price Hike Weighs Down Growth
Qualcomm Acquiring Chipmaker in the UK
Qualcomm Acquiring Chipmaker in the UK
Burberry Sales Up in First Half, but Market is Much Tougher
Burberry Sales Up in First Half, but Market is Much Tougher


Leave a Reply

 
Advertisement
Advertisement
© 2006-2014 WKRB News.